High-altitude hypoxia and periodic breathing during sleep: gender-related differences

J Sleep Res. 2013 Jun;22(3):322-30. doi: 10.1111/jsr.12012. Epub 2013 Jan 7.

Abstract

High-altitude exposure is characterized by the appearance of periodic breathing during sleep. Only limited evidence is available, however, on the presence of gender-related differences in this breathing pattern. In 37 healthy subjects, 23 male and 14 female, we performed nocturnal cardio-respiratory monitoring in the following conditions: (1) sea level; (2) first/second night at an altitude of 3400 m; (3) first/second night at an altitude of 5400 m and after a 10 day sojourn at 5400 m. At sea level, a normal breathing pattern was observed in all subjects throughout the night. At 3400 m the apnea-hypopnea index was 40.3 ± 33.0 in males (central apneas 77.6%, central hypopneas 22.4%) and 2.4 ± 2.8 in females (central apneas 58.2%, central hypopneas 41.8%; P < 0.01). During the first recording at 5400 m, the apnea-hypopnea index was 87.5 ± 35.7 in males (central apneas 60.0%, central hypopneas 40.0%) and 41.1 ± 44.0 in females (central apneas 73.2%, central hypopneas 26.8%; P < 0.01), again with a higher frequency of central events in males as seen at lower altitude. Similar results were observed after 10 days. With increasing altitude, there was also a progressive reduction in respiratory cycle length during central apneas in males (26.9 ± 3.4 s at 3400 m and 22.6 ± 3.7 s at 5400 m). Females, who displayed a significant number of central apneas only at the highest reached altitude, were characterized by longer cycle length than males at similar altitude (30.1 ± 5.8 s at 5400 m). In conclusion, at high altitude, nocturnal periodic breathing affects males more than females. Females started to present a significant number of central sleep apneas only at the highest reached altitude. After 10 days at 5400 m gender differences in the apnea-hypopnea index similar to those observed after acute exposure were still observed, accompanied by differences in respiratory cycle length.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Actigraphy
  • Adult
  • Altitude
  • Altitude Sickness / drug therapy
  • Altitude Sickness / etiology
  • Altitude Sickness / physiopathology
  • Angiotensin II Type 1 Receptor Blockers / administration & dosage
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Atmospheric Pressure
  • Benzimidazoles / administration & dosage
  • Benzimidazoles / pharmacology
  • Benzoates / administration & dosage
  • Benzoates / pharmacology
  • Blood Pressure Monitoring, Ambulatory / instrumentation
  • Double-Blind Method
  • Female
  • Heart Rate / physiology
  • Humans
  • Hypoxia / complications*
  • Hypoxia / etiology
  • Male
  • Middle Aged
  • Monitoring, Ambulatory / instrumentation*
  • Monitoring, Ambulatory / standards
  • Oxygen / blood
  • Placebos
  • Respiratory Rate / physiology
  • Severity of Illness Index
  • Sex Factors
  • Sleep / physiology*
  • Sleep Apnea, Central / drug therapy
  • Sleep Apnea, Central / etiology
  • Sleep Apnea, Central / physiopathology*
  • Telmisartan
  • Time Factors

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Benzimidazoles
  • Benzoates
  • Placebos
  • Oxygen
  • Telmisartan